New research article in The Lancet Infectious Diseases>
Effectiveness of #nirmatrelvir–#ritonavir in preventing hospital admissions and deaths in people with #COVID19: a cohort study in a large US health-care system
https://www.thelancet.com/journals/laninf/article/PIIS1473-3099%2823%2900118-4/fulltext
#COVID19 #Ritonavir #Nirmatrelvir
New research article in The Lancet Infectious Diseases>
Real-world use of #nirmatrelvir–#ritonavir in outpatients with #COVID19 during the era of omicron variants including BA.4 and BA.5 in Colorado, USA: a retrospective cohort study
https://www.thelancet.com/journals/laninf/article/PIIS1473-3099(23)00011-7/fulltext
#COVID19 #Ritonavir #Nirmatrelvir
New in the International Journal of Infectious Diseases, co-authored by Assistant in Biostatistics Kimberly W. Hart with colleagues Alexander M. Kaizer at University of Colorado, Wesley H. Self at Vanderbilt University Medical Center (Emergency Medicine), and more. https://doi.org/10.1016/j.ijid.2022.12.028 #COVID19 #lopinavir #ritonavir #RCTs #ClinicalTrials
#COVID19 #Lopinavir #Ritonavir #RCTs #clinicaltrials